Identification of Virulence Mutants of the Fungal Pathogen Cryptococcus neoformans Using Signature-Tagged Mutagenesis

Corresponding author: Jennifer K. Lodge, Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, 1402 S. Grand Blvd., St. Louis, MO 63104., lodgejk{at}slu.edu (E-mail)

Communicating editor: J. ARNOLD

Cryptococcus neoformans var. neoformans is an important opportunistic fungal pathogen of patients whose immune system has been compromised due to viral infection, antineoplastic chemotherapy, or tissue transplantation. As many as 13% of all AIDS patients suffer a life-threatening cryptococcal infection at some time during the course of their HIV disease. To begin to understand the molecular basis for virulence in Cryptococcus neoformans var. neoformans serotype A, we have employed signature-tagged mutagenesis (STM) to identify mutants with altered virulence in a mouse model. The critical parameters of signature-tagged mutagenesis in C. neoformans are explored. Data are presented showing that at least 100 different strains can be mixed together in a single animal with each participating in the infection and that there is no apparent interaction between a virulent strain and an avirulent strain in our animal model. Using signature-tagged mutagenesis, we identified 39 mutants with significantly altered growth in a competitive assay. Molecular analyses of these mutants indicated that 19 (49%) contained an insertion in the actin promoter by homologous recombination from a single crossover event, creating a duplication of the actin promoter and the integration of single or multiple copies of the vector. Analysis of the chromosomal insertion sites of those mutants that did not have an integration event in the actin promoter revealed an approximately random distribution among the chromosomes. Individual challenge of the putative mutants in a mouse model revealed five hypovirulent mutants and one hypervirulent mutant.

This article has been cited by other articles:

				J. S. Klutts and T. L. Doering Cryptococcal Xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans Plays a Direct Role in the Synthesis of Capsule Polysaccharides J. Biol. Chem., May 23, 2008; 283(21): 14327 - 14334. [Abstract] [Full Text] [PDF]

				M. B. Frankel, D. G. Mordue, and L. J. Knoll Discovery of parasite virulence genes reveals a unique regulator of chromosome condensation 1 ortholog critical for efficient nuclear trafficking PNAS, June 12, 2007; 104(24): 10181 - 10186. [Abstract] [Full Text] [PDF]

				A. Yoneda and T. L. Doering A Eukaryotic Capsular Polysaccharide Is Synthesized Intracellularly and Secreted via Exocytosis Mol. Biol. Cell, December 1, 2006; 17(12): 5131 - 5140. [Abstract] [Full Text] [PDF]

				E. E. McClelland, P. Bernhardt, and A. Casadevall Estimating the Relative Contributions of Virulence Factors for Pathogenic Microbes Infect. Immun., March 1, 2006; 74(3): 1500 - 1504. [Abstract] [Full Text] [PDF]

				R. J. Tang, J. Breger, A. Idnurm, K. J. Gerik, J. K. Lodge, J. Heitman, S. B. Calderwood, and E. Mylonakis Cryptococcus neoformans Gene Involved in Mammalian Pathogenesis Identified by a Caenorhabditis elegans Progeny-Based Approach Infect. Immun., December 1, 2005; 73(12): 8219 - 8225. [Abstract] [Full Text] [PDF]

				J. K. Hicks, Y.-S. Bahn, and J. Heitman Pde1 Phosphodiesterase Modulates Cyclic AMP Levels through a Protein Kinase A-Mediated Negative Feedback Loop in Cryptococcus neoformans Eukaryot. Cell, December 1, 2005; 4(12): 1971 - 1981. [Abstract] [Full Text] [PDF]

				E. Mylonakis, R. Moreno, J. B. El Khoury, A. Idnurm, J. Heitman, S. B. Calderwood, F. M. Ausubel, and A. Diener Galleria mellonella as a Model System To Study Cryptococcus neoformans Pathogenesis Infect. Immun., July 1, 2005; 73(7): 3842 - 3850. [Abstract] [Full Text] [PDF]

				Y. Apidianakis, L. G. Rahme, J. Heitman, F. M. Ausubel, S. B. Calderwood, and E. Mylonakis Challenge of Drosophila melanogaster with Cryptococcus neoformans and Role of the Innate Immune Response Eukaryot. Cell, April 1, 2004; 3(2): 413 - 419. [Abstract] [Full Text] [PDF]

				A. Idnurm, J. L. Reedy, J. C. Nussbaum, and J. Heitman Cryptococcus neoformans Virulence Gene Discovery through Insertional Mutagenesis Eukaryot. Cell, April 1, 2004; 3(2): 420 - 429. [Abstract] [Full Text] [PDF]

				P. T. Magee, C. Gale, J. Berman, and D. Davis Molecular Genetic and Genomic Approaches to the Study of Medically Important Fungi Infect. Immun., May 1, 2003; 71(5): 2299 - 2309. [Full Text] [PDF]

				E. Mylonakis, F. M. Ausubel, J. R. Perfect, J. Heitman, and S. B. Calderwood Killing of Caenorhabditiselegans by Cryptococcus neoformans as a model of yeast pathogenesis PNAS, November 26, 2002; 99(24): 15675 - 15680. [Abstract] [Full Text] [PDF]

				T. H. Rude, D. L. Toffaletti, G. M. Cox, and J. R. Perfect Relationship of the Glyoxylate Pathway to the Pathogenesis of Cryptococcus neoformans Infect. Immun., October 1, 2002; 70(10): 5684 - 5694. [Abstract] [Full Text] [PDF]

				R. C. Davidson, J. R. Blankenship, P. R. Kraus, M. de Jesus Berrios, C. M. Hull, C. D'Souza, P. Wang, and J. Heitman A PCR-based strategy to generate integrative targeting alleles with large regions of homology Microbiology, August 1, 2002; 148(8): 2607 - 2615. [Abstract] [Full Text] [PDF]